Doctors at Scripps Health studied the outcomes of people who switched to a reduced dosing schedule of their GLP-1 therapy. They found that people generally maintained their weight loss and other improved health markers, even if they dosed as little as once every two months. Though still preliminary, the results suggest it could be easier and more affordable to stay on GLP-1s long-term than is currently assumed.
It's started, it's just unevenly distributed among the poorer populations